Workflow
Trust Chem(001335)
icon
Search documents
信凯科技12月19日获融资买入440.24万元,融资余额1.06亿元
Xin Lang Cai Jing· 2025-12-22 01:41
Core Viewpoint - Xinkai Technology's stock performance shows a slight increase, but financing activities indicate a net outflow, reflecting potential investor caution amid declining revenue and profit figures [1][2]. Group 1: Stock Performance and Financing - On December 19, Xinkai Technology's stock rose by 0.37%, with a trading volume of 52.72 million yuan [1]. - The financing data for December 19 shows a financing buy of 4.40 million yuan and a financing repayment of 14.85 million yuan, resulting in a net financing outflow of 10.45 million yuan [1]. - As of December 19, the total financing and securities balance for Xinkai Technology is 106 million yuan, which accounts for 9.91% of its market capitalization [1]. Group 2: Shareholder and Financial Performance - As of December 10, the number of shareholders for Xinkai Technology is 7,552, a decrease of 18.31% from the previous period [2]. - The average number of circulating shares per shareholder is 3,103, which has increased by 22.42% [2]. - For the period from January to September 2025, Xinkai Technology reported a revenue of 1.02 billion yuan, a year-on-year decrease of 2.85%, and a net profit attributable to shareholders of 64.09 million yuan, down 11.21% year-on-year [2].
信凯科技涨2.08%,成交额3008.71万元,主力资金净流入24.25万元
Xin Lang Cai Jing· 2025-12-18 03:36
Group 1 - The core viewpoint of the news is that Xinkai Technology's stock has shown fluctuations, with a recent increase of 2.08% and a current price of 46.60 yuan per share, while the company has experienced an 11.51% decline in stock price year-to-date [1] - As of December 10, the number of shareholders for Xinkai Technology is 7,552, a decrease of 18.31% from the previous period, while the average circulating shares per person increased by 22.42% to 3,103 shares [2] - The company has reported a revenue of 1.024 billion yuan for the period from January to September 2025, reflecting a year-on-year decrease of 2.85%, and a net profit attributable to shareholders of 64.0945 million yuan, down 11.21% year-on-year [2] Group 2 - Xinkai Technology's main business involves the development, sales, and service of organic pigments, with the revenue composition being 65.59% from azo pigments, 19.30% from heterocyclic pigments, and smaller contributions from other pigment types [1] - The company has cumulatively distributed 14.0609 million yuan in dividends since its A-share listing [3] - The company is categorized under the basic chemical industry, specifically in chemical products related to coatings and inks, and is associated with concepts such as the Belt and Road Initiative and small-cap stocks [2]
信凯科技:关于变更2025年度审计机构项目质量控制复核人的公告
(编辑 王雪儿) 证券日报网讯 12月17日晚间,信凯科技发布公告称,中汇会计师事务所受公司委托为公司提供2025年 度财务报告及内部控制审计服务,原指派许菊萍女士担任公司2025年度审计项目质量控制复核人,因中 汇会计师事务所质控工作内部调整及工作安排的需要,现指派孙业亮先生担任质量控制复核人。 ...
信凯科技(001335) - 关于变更2025年度审计机构项目质量控制复核人的公告
2025-12-17 08:15
证券代码:001335 证券简称:信凯科技 公告编号:2025-038 浙江信凯科技集团股份有限公司 关于变更 2025 年度审计机构项目质量控制复核人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 浙江信凯科技集团股份有限公司(以下简称"公司")于2025年6月3日召开 第二届董事会第八次会议及第二届监事会第六次会议,审议通过了《关于续聘中 汇会计师事务所(特殊普通合伙)担任公司2025年度审计机构的议案》,同意续 聘中汇会计师事务所(特殊普通合伙)(以下简称"中汇会计师事务所")为公 司2025年度审计机构,该议案已于2025年6月25日经公司2024年度股东会审议通 过。具体内容详见公司于2025年6月5日、2025年6月25日在巨潮资讯网 (www.cninfo.com.cn)上刊登的《关于续聘2025年度审计机构的公告》(公告 编号:2025-022)等公告。 二、本次变更的质量控制复核人信息 1. 基本信息 | | | 成为注册 | | 开始从事上 | | 开始在中汇 | | 开始为本 | 近三年签署及 | | --- | --- | -- ...
信凯科技:截至12月10日公司股东总户数为7552户
Zheng Quan Ri Bao Wang· 2025-12-12 08:14
Group 1 - The core point of the article is that Xinkai Technology (001335) reported its total number of shareholders as 7,552 as of December 10 [1]
信凯科技(001335.SZ):公司的研发费用较低,主要是由于研发模式和研发方向的差异
Ge Long Hui· 2025-12-11 15:35
答:相较同行业的其他上市公司,公司的研发费用较低,主要是由于研发模式和研发方向的差异。同行 业其他上市企业是以生产制造为主,因此从技术研发、小试中试过程、生产研发设备、原料、人员工资 等方面均有较高支出。而公司的研发更侧重于产品开发、应用开发以及产品定制化服务,研发费用更多 的是实验室阶段的技术投入成本及人员费用;随着公司自有制造基地及未来研发中心的投入使用,公司 的研发费用预计将有一定幅度的增长。 格隆汇12月11日丨信凯科技(001335.SZ)在投资者关系中表示,有被问到: 公司的研发费用较国内同行相 比较少,主要是什么原因? ...
信凯科技(001335.SZ):目前信凯紫源工厂正处于试生产阶段,预计试产将持续一年左右
Ge Long Hui· 2025-12-11 15:35
Core Viewpoint - Xinkai Technology (001335.SZ) is currently in the trial production phase for its subsidiary, Liaoning Xinkai Ziyuan New Materials Co., Ltd, which is expected to last approximately one year [1] Group 1: Production Status - The factory is designed according to the latest national safety standards and employs a full-process microchannel technology [1] - The production ramp-up period is influenced by market demand and product competitiveness, with typical chemical companies taking about 2-3 years to reach full production after official launch [1] - The actual timeline for achieving full production is difficult to predict due to the new challenges posed by the new technology in product manufacturing [1]
信凯科技(001335.SZ):公司的主要收入来源是海外市场
Ge Long Hui· 2025-12-11 15:35
Core Viewpoint - The company emphasizes that its overseas sales network is a significant advantage, contributing to its leading position in the organic pigment export industry for nearly a decade [1] Group 1: Overseas Market Contribution - The primary revenue source for the company is the overseas market, with approximately 87% of its business coming from international sales in the first half of 2025 [1] - The company has established a presence in over 70 countries and regions through nearly 30 years of overseas market development [1] Group 2: Sales Network Strategy - The company operates seven subsidiaries in major overseas markets, employing local professional sales personnel for efficient customer engagement and service [1] - To address customer demand uncertainties and supply timeliness, the company has set up warehousing and logistics centers in key sales regions for organic pigments, enabling prompt responses to customer needs [1] - The company combines technical services with product sales to cater to diverse customer applications, ensuring seamless connection from customer requirements to product development and performance improvement, which significantly enhances customer loyalty [1]
信凯科技:目前信凯紫源工厂正处于试生产阶段,预计试产将持续一年左右
Ge Long Hui· 2025-12-11 15:32
Core Viewpoint - Xinkai Technology (001335.SZ) is currently in the trial production phase for its subsidiary, Liaoning Xinkai Ziyuan New Materials Co., Ltd, which is expected to last approximately one year [1] Group 1: Production Status - Liaoning Xinkai Ziyuan New Materials Co., Ltd is designed according to the latest national safety standards and employs a full-process microchannel technology [1] - The factory is facing new challenges in product production due to the new technology, which may extend the time required to streamline all processes and product models [1] Group 2: Production Timeline - The time to reach full production capacity is influenced by various factors, including market demand and product competitiveness [1] - Generally, the production ramp-up period for chemical companies is about 2-3 years after official production begins, but actual achievement timelines are difficult to predict accurately [1]
信凯科技:贸易壁垒问题对公司经营造成的影响有限
Core Viewpoint - The company believes that despite international trade tensions and barriers, the demand for its products from overseas clients remains strong due to the irreplaceable nature of many of its offerings [1] Group 1: Impact of International Trade - The company's sales operations are globally distributed, with a significant portion of its business being export-oriented [1] - A large share of products sold in overseas markets is manufactured in China, which is crucial for maintaining client relationships [1] Group 2: Cost Management Strategies - The company has a price adjustment mechanism in place that allows it to pass on most of the additional costs incurred due to trade barriers to downstream customers [1] - The impact of international trade issues on the company's operations is considered limited due to this pricing strategy [1]